NovoCure denied FDA approval of Optune Mya for brain metastases
at seekingalpha.com (Tue, 10-Nov 10:03 AM)
NovoCure Receives FDA Not Approvable Letter for Optune Mya
at www.tipranks.com (Mon, 9-Nov 7:38 AM)
Novocure raises 2026 guidance after record quarterly revenue and 19% growth in active patients
Market Chameleon (Thu, 29-Oct 8:42 AM)
